Broadfin Healthcare Master Fund Ltd Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Broadfin Healthcare Master Fund Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Broadfin Healthcare Master Fund Ltd. Broadfin Healthcare Master Fund Ltd is 10% Owner in NOVELION THERAPEUTICS INC. ($QLTI) and Director in NOVELION THERAPEUTICS INC. ($NVLN) and 10% Owner in PROGENICS PHARMACEUTICALS INC ($PGNX) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($FLML) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and 10% Owner in STRATA Skin Sciences, Inc. ($MELA) and 10% Owner in Aegerion Pharmaceuticals, Inc. ($AEGR) and 10% Owner in ARATANA THERAPEUTICS, INC. ($PETX) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Recro Pharma, Inc. ($REPH).
Latest Insider Trading Transactions of Broadfin Healthcare Master Fund Ltd
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, PETX, AVDL, BDSI, CORI, MYG, NVLN, PGNX, REPH, MELA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2020 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Option Exercise | C | 2.93 | 10,623 | 31,125 | 37,500 | |
| Mar 19 2020 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | M | 2.93 | 10,623 | 31,125 | 4,310,689 | 4.3 M to 4.3 M (-0.25 %) |
| Dec 20 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Option Exercise | C | 1.80 | 360 | 648 | 436 | |
| Dec 20 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Buy | C | 1.80 | 2,000,000 | 3,600,000 | 4,300,066 | 2.3 M to 4.3 M (+86.95 %) |
| Dec 20 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 6.32 | 1,000,000 | 6,320,000 | 2,300,066 | 3.3 M to 2.3 M (-30.30 %) |
| Dec 20 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 6.50 | 750,000 | 4,875,000 | 3,300,066 | 4.1 M to 3.3 M (-18.52 %) |
| Dec 20 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 6.44 | 250,000 | 1,610,000 | 4,050,066 | 4.3 M to 4.1 M (-5.81 %) |
| Nov 19 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Option Exercise | C | 1.80 | 720 | 1,296 | 796 | |
| Nov 19 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Buy | C | 1.80 | 4,000,000 | 7,200,000 | 4,300,066 | 300.1 K to 4.3 M (+1,333.04 %) |
| Nov 19 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 5.90 | 1,500,000 | 8,850,000 | 300,066 | 1.8 M to 300.1 K (-83.33 %) |
| Nov 19 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 5.90 | 293,757 | 1,734,165 | 1,800,066 | 2.1 M to 1.8 M (-14.03 %) |
| Nov 19 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 6.04 | 2,206,243 | 13,319,089 | 2,093,823 | 4.3 M to 2.1 M (-51.31 %) |
| Jul 22 2019 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | D | 0.00 | 7,258,135 | 0 | 0 | 7.3 M to 0 (-100.00 %) |
| May 14 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Option Exercise | C | 1.80 | 324 | 583 | 1,516 | |
| May 14 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 5.00 | 1,800,000 | 9,000,000 | 4,281,943 | 6.1 M to 4.3 M (-29.60 %) |
| Apr 15 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Option Exercise | C | 1.80 | 360 | 648 | 1,840 | |
| Apr 15 2019 | BDSI | BIODELIVERY SCIENC ... | Broadfin Healthcare Master Fun ... | Director | Sell | S | 5.00 | 2,000,000 | 10,000,000 | 4,281,943 | 6.3 M to 4.3 M (-31.84 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.85 | 100,000 | 85,140 | 1,498,553 | 1.6 M to 1.5 M (-6.26 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.85 | 56,316 | 48,139 | 1,598,553 | 1.7 M to 1.6 M (-3.40 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.88 | 14,800 | 13,028 | 1,654,869 | 1.7 M to 1.7 M (-0.89 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.91 | 30,726 | 27,868 | 1,669,669 | 1.7 M to 1.7 M (-1.81 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.91 | 28,745 | 26,037 | 1,700,395 | 1.7 M to 1.7 M (-1.66 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.91 | 12,219 | 11,108 | 1,729,140 | 1.7 M to 1.7 M (-0.70 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.87 | 109,900 | 95,833 | 1,741,359 | 1.9 M to 1.7 M (-5.94 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.91 | 12,450 | 11,302 | 1,851,259 | 1.9 M to 1.9 M (-0.67 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.98 | 83,245 | 81,447 | 1,863,709 | 1.9 M to 1.9 M (-4.28 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.93 | 1,200 | 1,119 | 1,946,954 | 1.9 M to 1.9 M (-0.06 %) |
| Dec 27 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 0.98 | 400 | 392 | 1,948,154 | 1.9 M to 1.9 M (-0.02 %) |
| Nov 28 2018 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | U | 0.00 | 4,474,995 | 0 | 0 | 4.5 M to 0 (-100.00 %) |
| Aug 13 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | G | 3.33 | 10,000 | 33,300 | 19,600 | |
| Aug 13 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | G | 3.33 | 10,000 | 33,300 | 19,600 | |
| May 24 2018 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.51 | 25,000 | 137,750 | 2,048,025 | 2.1 M to 2 M (-1.21 %) |
| May 24 2018 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.65 | 50,000 | 282,500 | 2,073,025 | 2.1 M to 2.1 M (-2.36 %) |
| May 24 2018 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.00 | 45,700 | 274,200 | 2,123,025 | 2.2 M to 2.1 M (-2.11 %) |
| May 24 2018 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.99 | 38,000 | 227,620 | 2,168,725 | 2.2 M to 2.2 M (-1.72 %) |
| May 24 2018 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.84 | 29,300 | 171,112 | 2,206,725 | 2.2 M to 2.2 M (-1.31 %) |
| Mar 19 2018 | NVLN | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | Director | Option Exercise | A | 4.40 | 909,296 | 4,000,902 | 909,296 | |
| Mar 15 2018 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.07 | 200,000 | 2,014,000 | 2,236,025 | 2.4 M to 2.2 M (-8.21 %) |
| Dec 22 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.80 | 40,000 | 392,000 | 2,436,025 | 2.5 M to 2.4 M (-1.62 %) |
| Dec 22 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.84 | 11,000 | 108,240 | 2,476,025 | 2.5 M to 2.5 M (-0.44 %) |
| Dec 22 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.00 | 25,000 | 250,000 | 2,487,025 | 2.5 M to 2.5 M (-1.00 %) |
| Dec 07 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.00 | 100,000 | 1,000,000 | 2,605,262 | 2.7 M to 2.6 M (-3.70 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.40 | 425,298 | 2,296,609 | 4,294,426 | 4.7 M to 4.3 M (-9.01 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.44 | 1,900 | 10,336 | 4,719,724 | 4.7 M to 4.7 M (-0.04 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.45 | 50,000 | 272,500 | 4,721,624 | 4.8 M to 4.7 M (-1.05 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.47 | 100 | 547 | 4,771,624 | 4.8 M to 4.8 M (0.00 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.52 | 5,110 | 28,207 | 4,771,724 | 4.8 M to 4.8 M (-0.11 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.53 | 8,020 | 44,351 | 4,776,834 | 4.8 M to 4.8 M (-0.17 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.65 | 72,000 | 406,800 | 4,784,854 | 4.9 M to 4.8 M (-1.48 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.90 | 50,000 | 295,000 | 4,856,854 | 4.9 M to 4.9 M (-1.02 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.95 | 50,000 | 297,500 | 4,906,854 | 5 M to 4.9 M (-1.01 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.95 | 100,000 | 595,000 | 4,956,854 | 5.1 M to 5 M (-1.98 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 5.97 | 11,472 | 68,488 | 5,056,854 | 5.1 M to 5.1 M (-0.23 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.03 | 100 | 603 | 5,068,326 | 5.1 M to 5.1 M (0.00 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.26 | 1,900 | 11,894 | 5,068,426 | 5.1 M to 5.1 M (-0.04 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.28 | 300 | 1,884 | 5,070,326 | 5.1 M to 5.1 M (-0.01 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.35 | 7,700 | 48,895 | 5,070,626 | 5.1 M to 5.1 M (-0.15 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.50 | 50,000 | 325,000 | 5,078,326 | 5.1 M to 5.1 M (-0.97 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.55 | 5,751 | 37,669 | 5,128,326 | 5.1 M to 5.1 M (-0.11 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.60 | 49,865 | 329,109 | 5,134,077 | 5.2 M to 5.1 M (-0.96 %) |
| Dec 01 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 6.66 | 1,000 | 6,660 | 5,183,942 | 5.2 M to 5.2 M (-0.02 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.61 | 100 | 961 | 2,705,262 | 2.7 M to 2.7 M (0.00 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 100,000 | 955,000 | 2,705,362 | 2.8 M to 2.7 M (-3.56 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 50,000 | 477,500 | 2,805,362 | 2.9 M to 2.8 M (-1.75 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.62 | 5,000 | 48,100 | 2,855,362 | 2.9 M to 2.9 M (-0.17 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.69 | 500 | 4,845 | 2,860,362 | 2.9 M to 2.9 M (-0.02 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.63 | 6,322 | 60,881 | 2,860,862 | 2.9 M to 2.9 M (-0.22 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 100 | 971 | 2,867,184 | 2.9 M to 2.9 M (0.00 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 6,381 | 61,960 | 2,867,284 | 2.9 M to 2.9 M (-0.22 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.66 | 3,764 | 36,360 | 2,873,665 | 2.9 M to 2.9 M (-0.13 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 700 | 6,776 | 2,877,429 | 2.9 M to 2.9 M (-0.02 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 2,200 | 21,296 | 2,878,129 | 2.9 M to 2.9 M (-0.08 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.56 | 21,619 | 206,678 | 2,880,329 | 2.9 M to 2.9 M (-0.74 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 1,500 | 14,520 | 2,901,948 | 2.9 M to 2.9 M (-0.05 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 24,430 | 237,215 | 2,903,448 | 2.9 M to 2.9 M (-0.83 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.37 | 5,900 | 55,283 | 2,927,878 | 2.9 M to 2.9 M (-0.20 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.48 | 1,450 | 13,746 | 2,933,778 | 2.9 M to 2.9 M (-0.05 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.39 | 5,800 | 54,462 | 2,935,228 | 2.9 M to 2.9 M (-0.20 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.31 | 2,051 | 19,095 | 2,941,028 | 2.9 M to 2.9 M (-0.07 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.32 | 2,913 | 27,149 | 2,943,079 | 2.9 M to 2.9 M (-0.10 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.36 | 3,088 | 28,904 | 2,945,992 | 2.9 M to 2.9 M (-0.10 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.37 | 48,566 | 455,063 | 2,949,080 | 3 M to 2.9 M (-1.62 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.37 | 2,440 | 22,863 | 2,997,646 | 3 M to 3 M (-0.08 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.50 | 100,000 | 950,000 | 3,000,086 | 3.1 M to 3 M (-3.23 %) |
| Nov 20 2017 | MYG | Mirati Therapeutic ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 18.05 | 60,000 | 1,083,000 | 2,728,601 | 2.8 M to 2.7 M (-2.15 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.95 | 25,000 | 273,750 | 3,568,626 | 3.6 M to 3.6 M (-0.70 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.96 | 9,255 | 101,435 | 3,593,626 | 3.6 M to 3.6 M (-0.26 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.95 | 100,000 | 1,095,000 | 3,602,881 | 3.7 M to 3.6 M (-2.70 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 11.01 | 65,345 | 719,448 | 3,702,881 | 3.8 M to 3.7 M (-1.73 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.97 | 400 | 4,388 | 3,768,226 | 3.8 M to 3.8 M (-0.01 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.88 | 25,000 | 272,000 | 3,768,626 | 3.8 M to 3.8 M (-0.66 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.85 | 25,000 | 271,250 | 3,793,626 | 3.8 M to 3.8 M (-0.65 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.97 | 250,000 | 2,742,500 | 3,818,626 | 4.1 M to 3.8 M (-6.14 %) |
| Nov 03 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 11.05 | 150,000 | 1,657,500 | 4,068,626 | 4.2 M to 4.1 M (-3.56 %) |
| Oct 06 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 11.01 | 218,100 | 2,401,107 | 4,218,626 | 4.4 M to 4.2 M (-4.92 %) |
| Jun 26 2017 | AVDL | AVADEL PHARMACEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.60 | 161,000 | 1,706,600 | 4,133,464 | 4.3 M to 4.1 M (-3.75 %) |
| Jun 26 2017 | AVDL | AVADEL PHARMACEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.80 | 100,000 | 1,080,000 | 4,294,464 | 4.4 M to 4.3 M (-2.28 %) |
| May 22 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | X | 7.50 | 7,295 | 54,713 | 0 | |
| May 22 2017 | PETX | ARATANA THERAPEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | X | 7.50 | 729,500 | 5,471,250 | 5,184,942 | 4.5 M to 5.2 M (+16.37 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 150,000 | 1,432,500 | 6,997,269 | 7.1 M to 7 M (-2.10 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 150,000 | 1,452,000 | 7,147,269 | 7.3 M to 7.1 M (-2.06 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 100,000 | 970,000 | 7,297,269 | 7.4 M to 7.3 M (-1.35 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 50,000 | 485,000 | 7,397,269 | 7.4 M to 7.4 M (-0.67 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 52,600 | 510,220 | 7,447,269 | 7.5 M to 7.4 M (-0.70 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 100,000 | 970,000 | 7,499,869 | 7.6 M to 7.5 M (-1.32 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.69 | 1,300 | 12,591 | 7,599,869 | 7.6 M to 7.6 M (-0.02 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.66 | 100,000 | 966,000 | 7,601,169 | 7.7 M to 7.6 M (-1.30 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.75 | 100,000 | 975,000 | 7,701,169 | 7.8 M to 7.7 M (-1.28 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.65 | 50,000 | 482,500 | 7,801,169 | 7.9 M to 7.8 M (-0.64 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.74 | 100,000 | 974,000 | 7,851,169 | 8 M to 7.9 M (-1.26 %) |
| Jan 13 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | D | 8.95 | 1,000,000 | 8,950,000 | 7,951,169 | 9 M to 8 M (-11.17 %) |
| Jan 06 2017 | FLML | AVADEL PHARMACEUTI ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | D | 0.00 | 4,394,464 | 0 | 0 | 4.4 M to 0 (-100.00 %) |
| Dec 27 2016 | QLTI | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | G | 8.65 | 9,600 | 83,040 | 9,600 | |
| Dec 27 2016 | QLTI | NOVELION THERAPEUT ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | G | 8.65 | 9,600 | 83,040 | 9,600 | |
| Dec 14 2016 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 6.00 | 650,000 | 3,900,000 | 3,100,086 | 2.5 M to 3.1 M (+26.53 %) |
| Dec 01 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | D | 0.00 | 4,361,291 | 0 | 0 | 4.4 M to 0 (-100.00 %) |
| Sep 14 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.75 | 75,000 | 131,250 | 4,361,291 | 4.3 M to 4.4 M (+1.75 %) |
| Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.70 | 76,000 | 129,200 | 4,286,291 | 4.2 M to 4.3 M (+1.81 %) |
| Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.70 | 100,000 | 169,600 | 4,210,291 | 4.1 M to 4.2 M (+2.43 %) |
| Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.60 | 100,000 | 159,500 | 4,110,291 | 4 M to 4.1 M (+2.49 %) |
| Aug 17 2016 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 7.50 | 390,000 | 2,925,000 | 2,450,086 | 2.1 M to 2.5 M (+18.93 %) |
| Aug 17 2016 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 7.50 | 390,000 | 2,925,000 | 2,450,086 | 2.1 M to 2.5 M (+18.93 %) |
| Mar 14 2016 | MELA | STRATA Skin Scienc ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 1.28 | 200,000 | 256,000 | 1,008,297 | 1.2 M to 1 M (-16.55 %) |
| Mar 14 2016 | MELA | STRATA Skin Scienc ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 1.05 | 16,000 | 16,800 | 1,208,297 | 1.2 M to 1.2 M (-1.31 %) |
| Mar 14 2016 | MELA | STRATA Skin Scienc ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 1.50 | 25,000 | 37,500 | 1,224,297 | 1.2 M to 1.2 M (-2.00 %) |
| Mar 14 2016 | MELA | STRATA Skin Scienc ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 1.50 | 23,500 | 35,250 | 1,249,297 | 1.3 M to 1.2 M (-1.85 %) |
| Mar 14 2016 | MELA | STRATA Skin Scienc ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 1.51 | 1,500 | 2,265 | 1,272,797 | 1.3 M to 1.3 M (-0.12 %) |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | X | 7.50 | 4,976 | 37,320 | 0 | |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | E | 17.50 | 5,000 | 87,500 | 0 | |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | X | 7.50 | 24 | 180 | 0 | |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | X | 7.50 | 497,600 | 3,732,000 | 4,010,291 | 3.5 M to 4 M (+14.17 %) |
| Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | X | 7.50 | 2,400 | 18,000 | 3,512,691 | 3.5 M to 3.5 M (+0.07 %) |
| Nov 13 2015 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 10.96 | 35,000 | 383,600 | 4,010,291 | 4 M to 4 M (+0.88 %) |
| Nov 13 2015 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 10.99 | 5,100 | 56,049 | 3,975,291 | 4 M to 4 M (+0.13 %) |
| Jul 09 2015 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 11.60 | 646,553 | 7,500,015 | 2,060,086 | 1.4 M to 2.1 M (+45.74 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.73 | 388,659 | 1,838,357 | 8,951,169 | 8.6 M to 9 M (+4.54 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.73 | 388,200 | 1,836,186 | 8,562,510 | 8.2 M to 8.6 M (+4.75 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.48 | 436,884 | 1,957,240 | 8,174,310 | 7.7 M to 8.2 M (+5.65 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.48 | 411,693 | 1,844,385 | 7,737,426 | 7.3 M to 7.7 M (+5.62 %) |
Page: 1